TTOO
PINK T2 Biosystems, Inc.$0.0006 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0006, and at the day’s high of $0.0006
- YTD change
- -88.00%
- vs 20-day SMA
- -22.08%
- vs 200-day SMA
- -84.08%
Price ranges
Price & Performance
+0.00 (+200.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $49,900.0000
- TTOO is down 88% since the beginning of the year
- TTOO is down 95% over the past 12 months
- TTOO is down 40% over the past 1 month
- 0% of all TTOO investors are betting against TTOO
TTOO reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -95.2%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +20.00%
No alerts for TTOO in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.